IGCS Education360 Podcast

Insights into the Evolving Landscape of Endometrial Cancer Panel Discussion

The panel explores innovations in surgery, medical therapies—including immunotherapy and targeted treatments—supportive care strategies, and prevention, offering practical takeaways and forward-looking insights to improve patient outcomes.
Moderator: Dr. Brian Slomovitz
Panelists: Dr. Angelica Rodriguez, Dr. Tom Herzog, and Courtney Arn
Special thank you to The GOG Foundation Inc for providing recording support. https://www.gog.org/

Malignant Bowel Obstruction in Gynecologic Cancers Episode 5: End of Life Decisions, Conflict, Care for the Care Team.

Dr. Michael Pearl (USA) discusses end of life decisions, conflicts, and how multidisciplinary teams can support patients, caregivers, and team members in managing unresolved or complex MBO cases.
This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care. Each episode is hosted the IGCS Education Palliative Care workgroup co-chairs, Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) and features an expert, guest speaker sharing their knowledge on MBO.

Malignant Bowel Obstruction in Gynecologic Cancers Episode 4: Surgical Interventions

Dr. Glauco Baiocchi (Brazil) shares when surgery is indicated for MBO, reviewing specific procedures, risks and benefits, and how to apply current evidence to guide surgical decision-making.This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care. Each episode is hosted the IGCS Education Palliative Care workgroup co-chairs, Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) and features an expert, guest speaker sharing their knowledge on MBO.

Malignant Bowel Obstruction in Gynecologic Cancers Episode 3: Management Strategies – To Operate or Not?

Dr. Aditi Bhatt (India) discusses non-surgical strategies for managing malignant bowel obstruction, highlighting symptom control, medication use, and the importance of tailoring care based on the site and cause of obstruction.
This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care. Each episode is hosted the IGCS Education Palliative Care workgroup co-chairs, Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) and features an expert, guest speaker sharing their knowledge on MBO.

Malignant Bowel Obstruction in Gynecologic Cancers Episode 2: Decision-Making, Ethics, and Communication

Dr. Eduardo Burera (USA) explores the ethical and emotional complexities of MBO care, highlighting shared decision-making, difficult conversations, and the role of the multidisciplinary palliative care team.
This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care. Each episode is hosted the IGCS Education Palliative Care workgroup co-chairs, Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) and features an expert, guest speaker sharing their knowledge on MBO.

Malignant Bowel Obstruction in Gynecologic Cancers Episode 1: The Big Picture – What Is Malignant Bowel Obstruction?

Dr. Stephanie Lheureux (Canada) introduces MBO in gynecologic cancers, discussing a through a case presentation and diagnostic challenges, with an emphasis on ovarian cancer and quality of life.
This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care. Each episode is hosted the IGCS Education Palliative Care workgroup co-chairs, Dr. Peter Grant (Australia) and Dr. Anisa Mburu (Kenya) and features an expert, guest speaker sharing their knowledge on MBO.

Multidisciplinary Conversations with Radiation Oncologist David Gaffney

IGCS Education360 Radiation Oncology Workgroup, chaired by Dr. Pearly Khaw, interview with IGCS radiation oncologist board member Dr. David Gaffney. Through his  years of leadership and clinical experience, Dr. Gaffney shares his insights on integrating radiation oncology into the broader cancer care team to reflections on mentorship, research, and global equity in gynecologic oncology. 

Vulvar Cancer with HIV Nursing Tumor Board

IGCS nursing workgroup bimonthly tumor board and discussed nursing care options for a vulvar cancer patient with HIV experiencing incomplete treatment and gaps in follow-up.  
Case presentation by Biemba Maliti (Zambia)Moderated by Anne Mellon, RN (Australia), Chrissy Donovan, RN, NP (USA), and Sarah Belton, RN (Ireland)Join future IGCS nursing tumor boards by registering through iECHO.  If have a case you would like to present for discussion, please contact education@igcs.org.  

Immunotherapy Toxicities Nursing Tumor Board

IGCS nursing workgroup held their first tumor board and discussed nursing care options for a cervical cancer patient experiencing immunotherapy toxicities. 
Case presentation by Sarah Belton, RN (Ireland)Moderated by Anne Mellon, RN (Australia) and Chrissy Donovan, RN (USA)Interested in joining future IGCS nursing tumor boards, or have a case you would like to present for discussion, please contact education@igcs.org.  

Journal Club: Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

Listen to a new Journal Club with PI Dr. Brian Slomovitz and moderator Dr. Leslie Randall as they discuss details on the New England Journal of Medicine published article Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
Click here to read the article
Presented byBrian SlomovitzDirector of Gynecologic Oncology Co-Chair, Cancer Research CommitteeMount Sinani Medical CenterUSA
Moderated byLeslie RandallDirector of Gynecologic Oncology Clinical Research and Gynecologic Cancer Service LineInova Schar Cancer InstituteInova Health System USA
Supported in part by Pfizer | Genmab